SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

SMILES INCLUSIVE LIMITED(SIL)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of SIL: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Link Market Services,Level 21, 10 Eagle Street Brisbane QLD 4000

Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000005092
Address: C/- Talbot Sayer Level 27, 123 Eagle Street Brisbane QLD 4000
Tel:  07 5568 7645 Fax: 

Date first listed: 27/04/2018
Company Secretary: Andrew Ritter
Sector: Health Care Equipment & Services Industry Group: 
Activities: Roll-up of dental practices

News & Events

Expand this box to read and print

OFX Transferring Money Internationally to Free

The company has not been able to raise the funds required to repay amounts due under the recently anounced release deed with NAB. NAB has now terminated the release deed having earlier cancelled and demanded full payment of all amounts owing to it under its facilities on 19 October 2020. The Board has today appointed Luci Palaghia and Tim Heenan, Deloitte Restructuring Services partners, as Voluntary Administrators to Smiles Inclusive Limited and Totally Smiles Pty Ltd.

09/11/2020

The company lodges its Appendix 4C - quarterly.

30/10/2020

The company lodges an Appendix 4C - monthly.

30/10/2020

The company lodges its Half Yearly Report and Accounts.

28/10/2020

The company has agreed with NAB to revise the terms of the recently announced release deed. Under the deed, NAB has agreed to release and discharge the company from liability under its various banking facilitie on receipt of a payment of $12m plus amounts owing under the company's credit card facility and NAB's reasonable expenses associated with the facilities by 4 November 2020. The company is also required to repay amounts owing under its bank guarantee and JobKeeper facilities by 9 November 2020. The total debit balance held with NAB at close of business 19 October 2020 was $19,040,804. The company will not dispose of any assets prior to 4 November 2020, and it will close all transaction accounts with NAB, end the use of merchant facilities and replace bank guarantees on issue with third parties by 9 November 2020.

23/10/2020

The company has received a notice of intention to call a general meeting, which was provided by Dr. Arthur Mark Walsh, CDentist, Makepeace Nominees as trustee of the Makepeace Superfund Account, Dr. Philip Makepeace and Phi Long Invesment, indicating that they hold at least 5% of the votes that may be case at a general meeting of the company. The notice states an intention to appoint Dr Joao Camacho, Dr Philip Makepeace and Dr Arthur Walsh as directors of the company and to remove each of the directors of the company and any person appointed as a director of the company between 19 October 2020 and the date of the EGM. The requisitioners intend to hold the EGM no later than 21 December 2020. The company believes there is no reasonable basis for the requisitioners to repeatedly call a shareholder meeting to spill the Board.

20/10/2020

The shareholder meeting that was proposed to be held on 23 October 2020 at 10.00 am has been cancelled. There will be no extraordinary general meeting held on that date. The company has received a determination which prevents the company from using a transaction specific prospectus to raise capital until 19 October 2021.

19/10/2020

The company releases an Appendix 2A.

15/10/2020

The company issues a notice of Proposed issue of Securities - SIL.

15/10/2020

The Smiles Inclusive Board and management continue to make good progress in implementing the Sustainable Improvement Strategy and making the changes that will continue the encouraging turnaround of the business. An undewriting agreement with Aitken Murray Capital Partners to raise approximately $8 million to discharge liabilities to NAB was made. The new capital will be raised through a fully underwritten rights issue at 2.5 cents per share, which is anticipated to be completed on or around 7 December 2020. The Board is also in discussions with interested parties to refinance the balance of the existing NAB facilities and ensure the company has sufficient working capital to support the business.

13/10/2020

The company has signed an underwriting agreement with Aitken Murray Capital Partners and intends to raise approximatley $8 million via a fully underwritten rights issue at an issue price of 2.5c per share. The company anticipates it will complete the rights issue on or around 7 December 2020, and proceeds are expected to be used to discharge liabilities to NAB.

09/10/2020

The company lodges its Appendix 4C - monthly.

29/09/2020

Smiles Inclusive Limited has today been served with documents filed in the Magistrates Court of Queensland by ASIC seeking orders pursuant to section 1274(11) of the Corporations Act 2001 for the Company to lodge its 31 December 2019 accounts in accordance with sections 302 and 320(1) of the Act within 28 days of receiving a court order to do so. The hearing is set for 10 November 2020. ASIC will withdraw the matter from court if the company lodges the requested documents with ASIC no later than one week before 10 November 2020. The company expects to be in a position to lodge its 31 December 2019 accounts before the date of the hearing.

24/09/2020

The company's shareholders will shortly receive the following documents regarding the EGM called by a group of Totally Smiles dentists and their associated entities to be held on Friday 23 October 2020 at 10.00am: Chairman's letter to shareholders, Sustainable Improvement Strategy and Proxy Form. The Directors unanimously recommend shareholders VOTE AGAINST all of the resolutions proposed by the Requisitioning Shareholders and that you IGNORE THE PROXY FORM SENT BY THEM. The Board introduces the company's 'Sustainable Improvement Strategy' which provides the business with a pathway to sustainable growth in the short and longer term, and addresses a number of critical areas as a matter of urgency.

23/09/2020

The company is still progressing its proposed capital raising and yesterday requested an extension to the date for repayment under the deed.

14/09/2020

The company issues a response to ASX Query.

04/09/2020

The company lodges its Appendix 4C - monthly.

02/09/2020

The company releases a letter from the Chairman. The Chairman provides an update on the current status of the business and the significant progress that has been made in the company's turnaround plan.

20/08/2020

Victoria has declared a state of disaster, increasing restrictions to stage four with The Australian Health Protection Principle Committee supporting the Victorian Governments move. The Australian Dental Association Victoria has advised effective from the 7 August 2020 dental centres operating within the metropolitan area of Victoria and Mitchell Shire must practice in accordance with Level 3 dental restrictions, while regional Victoria moves to level 2 restrictions. The company's Miranda and Yarram practices are on sale. The restructure of the dentures and mobile divisions resulted in the consolidation of 15 tenancies. The company also continues to be in advanced discussions for recapitalisation and remains focused on its recovery and sustainability strategy. It also has agreed to finalise its banking relationship with its primary financier NAB under a formal release deed. The audit review of the interim financial statements for the half-year ended 31 December 2019 is anticipated to be completed by no later than 31 August 2020. The full year audit work for the year ended 30 June 2020 is in progress and the company expects to have this finalised shortly in the near future.

20/08/2020

The company issues a Response to ASX Appendix 3X Query.

14/08/2020

The company releases an Appendix 3G.

11/08/2020

The company has yesterday received a notice pursuant to section 249N of the Corporations Act 2001 (Cth) from the Requisitioning Shareholders nominating Dr Joao Camacho, Dr Philip Makepeace and Dr Arthur Walsh to be appointed directors of the Company, in addition to the removal of the current directors.

05/08/2020

The company has received a notice from Phi Long Investment, CDentist, Philip Makepeace, Arthur Mark Walsh and Makepeace as trustee of the Makepeace Superfund Account indicating that they hold more than 5% of the votes that may be cast at a general meeting of the company and that they intend to call and arrange to hold a general meeting of the company. The notice states an intention to move resolutions to remove each of directors of the company and to remove any person appointed as director on and from 3 August 2020 until the commencement of the general meeting. The requisitioning shareholders do not propose alternative directors in the notice.

03/08/2020

The company lodges its Appendix 4C - quarterly.

31/07/2020

The company issues a response to ASX Query.

20/07/2020

The company releases an Appendix 2A.

30/06/2020

The company releases a notice of Proposed issue of Securities - SIL.

30/06/2020

The company has entered into a short-term loan agreement with HOLZRC, an entity controlled by Dr Richard Holzgrefe, to assist with immediate working capital requirements. HOLZRC has advanced $200,000 on an unsecured basis to the company at an interest rate of 10% per annum which will accrue on the balance owing. The terms of the loan agreement, which has a termination date of 27 July 2020, may be amended by written agreement between both parties. The company will grant Holzrc options to acquire 4,000,000 fully paid ordinary shares in the company. The Options vest and are exercisable immediately at $0.025, and unexercised options lapse and automatically expire on 25 August 2020.

30/06/2020

The company releases its response to an ASX Query.

25/06/2020

The company lodges its Appendix 4C - Amendment.

01/06/2020

The Company announces the reopening of all dental centres following the Australian Health Protection Principle Committees approval to move to Level 1 dental services. The easing of restrictions means full dental services can be provided under the guidance of COVID-19 protocols.The period has also seen the Company progress its strategic planning, focusing on organisational redesign and consideration of the individual existing centres and businesses. This work has developed a clear pathway to cost efficiency, portfolio simplification and specific growth initiatives expected to maximise shareholder value.

15/05/2020

Totally Smiles is pleased to announce the easing of level 3 restrictions following the Australian Health Protection Principal Committee announcement. The business is now commencing its COVID-19 recovery plan with the re-opening of 20 practices from 27 April 2020. While the easing of restrictions is the first step in moving forward, the health and safety of our people and patients remains paramount. Totally Smiles will continue to adhere to AHPPC regulatory requirements, with an approach to increasing utilisation and opening the remaining practices in the coming weeks as the need for increased services arise.

01/05/2020

The company lodges an Appendix 4C.

01/05/2020

The company releases an Appendix 2A.

28/04/2020

The company received notice from Dr. John Camacho purporting to represent 16 of Totally Smiles' 98 dentists, seeking to terminate their service agreements. The company is in the process of contacting the dentists named in Dr Camacho's letter to understand their intentions and is committed to work with them wherever possible. The majority of those dentists have informed the company hat they were unaware of Dr Camacho's letter and have stated that it is not their intention to terminate their service agreements. In addition to dealing with the pandemic crisis, the Board and management are focused on the recovery of the business after COVID-19 and future growth plans. The commpany is in advanced negotiations in respect of the transaction which, if completed, would materially improve its financial positio and provide it with capital to continue through the remainder of the current temporary shutdown and beyond.

17/04/2020

The Company has agreed to grant its Deputy CEO, Michelle Aquilina, and its General Manager of Operations, Mark O'Brien, options to acquire 2,000,000 and 500,000 fully paid ordinary shares in the Company respectively.

14/04/2020

13,166,000 fully paid ordinary shares in the company are expected to be released from mandatory escrow on or around 27 April 2020.

08/04/2020

SIL has made the required alterations to its operating practices and model to support this approach, which has occurred in consideration of each of its practices and business individually. The majority of SIL's workforce has temporarily stood down, other than to meet the businesses' emergency appointment demand. It is anticipated that eligible employees will receive the Australian Government's JobKeeper subsidy of $1,500 per fortnight. Other initiatives underway include negotiations with landlords on deferred rental payments, discussions with major supplier contracts to renegotiate terms and application for federal and state government subsidies. The company is urgently seeking financial support from a range of prospective providers including to meet immediate obligations.

08/04/2020

The company releases an Appendix 3G.

12/03/2020

The company has received binding commitment for a placement to a sophisticated investor in Australia to raise $430,000. The offer price per fully paid ordinary share in the company is $0.038 and 11,315,789 New Shares will be issued. The cash generated from the placement will be used to meet its working capital requirements, and the investor has indicated that it would like to invest an additional $570,000 at the same price per share at a time before 30 June 2020.

10/03/2020

The company releases an Appendix 2A.

10/03/2020

The company releases a notice of Proposed issue of Securities - SIL.

10/03/2020

The securities of the company will be suspended from Official Quotation in accordance with Listing Rule 17.5 from the commencement oftrading today, 2 March 2020, following theirfailure to lodge the relevant periodic report by the due date.

02/03/2020

listed entity carried for record purposes only

27/04/2018

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    06/03/2019Tracy Penn44,117$0.170$7,500
    05/03/2019David Usasz50,000$0.190$9,500
    05/03/2019Peter D. Evans50,000$0.190$9,500
    31/12/2018David Usasz30,000$0.300$9,000
    19/12/2018David Usasz30,000$0.300$9,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    David UsaszChairman27/04/2018
    Genna LevitchNon Exec Director24/09/2020
    Michelle AquilinaDirector, CEO14/04/2020

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Peter FullerNon Exec Director25/06/201905/11/2020
    Peter D. EvansIndependent Director01/08/201823/09/2020
    Emma CorcoranCFO28/02/201915/05/2020
    Tony McCormackCEO28/02/201914/04/2020
    Tracy PennDeputy CEO27/04/201830/06/2019
    Mike TimoneyNon Exec Director27/04/201822/05/2019
    David HerlihyNon Exec Director27/04/201822/05/2019
    Paul InnesCFO28/02/2019
    Joshua LowcockIndependent Director17/09/201827/02/2019

    Date of first appointment, title may have changed.